Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in International Immunopharmacology
- Vol. 5 (1) , 97-101
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The registry of the international society for heart and lung transplantation: twentieth official adult heart transplant report—2003The Journal of Heart and Lung Transplantation, 2003
- Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2003
- Hypogammaglobulinemia after heart transplantation: impact of pre‐emptive use of immunoglobulin replacement (CytoGam®) on infection and rejection outcomesTransplant Infectious Disease, 2001
- Infectious Complications among 620 Consecutive Heart Transplant Patients at Stanford University Medical CenterClinical Infectious Diseases, 2001
- Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infectionThe Journal of Heart and Lung Transplantation, 2001
- Significant post‐transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?Transplant Infectious Disease, 2000
- Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipientsCurrent Opinion in Cardiology, 1998